◆ 会议时间：2023年6月13-16日
◆ 会议地点：美国 波特兰(Portland, OR)
◆ 会议简介：
2023年第56届美国流行病学研究学会(SER)年会将于2023年6月13-16日在美国波特兰举行。
美国流行病学研究学会(SER)成立于1968年，是世界上历史最悠久、规模最大的流行病学家组织，由来自约翰霍普金斯大学的Abraham Lilienfeld，纽约医学院的Milton Terris和哈佛大学的Brian MacMahon的三位流行病学系主任联合倡议组建。SER通过出版杂志（Epidemiology和 Epidemiologic Reviews）以及举办年会等宣形式，为相关专业人士提供一个展示研究成果、交流思想等平台。SER的使命是使流行病学家始终处于科学发展的最前沿。SER年会包括会前研讨会、全体会议、专题讨论会以及海报展示等形式，预计有超过1000名来自世界各地的专业人士参会。——未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)。
SER 2023 - 56th Annual Meeting of the Society for Epidemiologic Research
Date: June 13 – 16, 2023
Venue: Marriott Portland Downtown Waterfront, Portland, OR, USA
摘要征文投稿：
2023 ABSTRACT SUBMISSION DATES
General Abstract Submission:
November 8, 2022 – January 13, 2023 (11:00am EST)
NOTIFICATIONS WILL BE SENT BY: March 31, 2023
Latebreaker Abstract Submission:
February 7, 2023 – March 3, 2023 (11:00am EST)
NOTIFICATIONS WILL BE SENT BY: May 1, 2023
点此提交摘要>>>Submit Abstract>>>
Abstract Submission Policy
Abstracts derived from papers already published, either in print or in an online format, are not eligible for consideration to present at SER. Papers that have been accepted for publication but not yet published may be submitted but, in the event that the paper is published in advance of the SER meeting, the author is required to notify SER and withdraw the abstract from presentation.
Please use the following guidance to prepare your abstract:
All abstracts must be written in English and submitted through the online submission system. Use sentence case for your title.
Do not include references, tables, or mathematical equations in the abstract. Avoid acronyms and, where necessary, spell them out when used for the first time (common abbreviations in epidemiology such as OR, RR, RD, and CI do not need to be spelled out). Select a primary and secondary topic area from the list, which will be used to organize concurrent contributed sessions. The abstract should not exceed 2,000 characters, INCLUDING spaces. Title and author information are not included in the 2,000 character limit. One figure is allowed to accompany each abstract submission (optional).
Presentation of methodologic details and analysis results will assist reviewers in judging the quality of the research. Findings that advance knowledge are weighed more favorably than confirmation of established relations. Clarity and brevity of writing will allow evaluation of the importance of the research. Each abstract is scored by at least three reviewers.
For the general submission, the submitting author will be notified by email on or before March 31, 2023 with a final decision. Notifications for Late-breaking Abstracts will be sent on or before May 1, 2023. If you do not receive a notification, please contact Ms. Courtney Long (clong@epiresearch.org) after this date.
Late Breaking Abstract Policy
What is the difference between the General Abstract Submission and Late Breaking Abstract Submission?
1. The General Abstract Submission and Late Breaking Abstracts run on a different submission schedule.
2. All submission categories remain the same fro the General Abstract Submission and Late Breaking Abstract Submission
3. A higher percentage of abstracts are accepted through the General Abstract Submission.
4. Late Breaking Abstract Submissions will now require a short summary as to how the abstract qualifies as ‘late breaking’.
What is considered ‘late breaking’?
Generally, Late-breaking abstracts are those which are (i) of high relative urgency for dissemination (substantively or methodologically), and which (ii) for compelling reasons could not have been submitted under the regular deadline. Compelling reasons might include data becoming available for analysis after the General Abstract Submission due date. “I did not manage to finish my abstract on time” is unlikely to pass muster.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
